Pharmaceutical Technology-10-02-2010

Pharmaceutical Technology
From The Editor

October 02, 2010

The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.

Pharmaceutical Technology

The authors describe a technique designed to yield low-density powders with a tailored particle-size distribution over a broad range of respiratory flow rates.

Pharmaceutical Technology
Ingredients Insider

October 02, 2010

A recently released industry guide outlines a science- and risk-based approach to control the risk of cross-contamination.

Pharmaceutical Technology
Special Report

October 02, 2010

The growth of biologics is an important factor for the injectable-drug delivery systems market. A look at the technical and market considerations affecting this sector.

Pharmaceutical Technology
PharmTech Talk

October 02, 2010

Private companies and universities are developing new ways to deliver protein drugs.

Pharmaceutical Technology
News

October 02, 2010

Public-private R&D partnerships are on the rise across Europe, but national goals and academia-industry competition could prevent their success at the European level.

Pharmaceutical Technology
Outsourcing Outlook

October 02, 2010

Global pharmaceutical companies could have a problem getting rid of redundant facilities.

Pharmaceutical Technology
In the Spotlight

October 02, 2010

Editors' picks of pharmaceutical science and technology innovations.

Pharmaceutical Technology
Online Exclusives

October 02, 2010

An expert-panel-written book has surprising shortcomings.

Pharmaceutical Technology
Special Report

October 02, 2010

Drugmakers hatch new manufacturing paradigms in the wake of the 2009 H1N1 influenza pandemic.

Online Exclusives
Pharmaceutical Technology

October 02, 2010

The authors provide a brief overview of the European pharmaceutical regulation with regard to batch certification by a qualified person and batch release for the European market.

Agent-in Place
Pharmaceutical Technology

October 02, 2010

From disagreement to denial, being cordial about quality control can be challenging.

Online Exclusives
Pharmaceutical Technology

October 02, 2010

Pfizer's acquisition of Wyeth involves augmenting its biopharmaceutical product portfolio, pipeline, and related development and manufacturing capabilities.

Pharmaceutical Technology
Industry Leaders

October 02, 2010

The president of Gibraltar Laboratories, Daniel Prince, discusses industry trends and challenges.

News
Pharmaceutical Technology

October 02, 2010

A look at MVI's malaria work in developing countries.

Novartis' Matthew Stober discusses vaccine manufacturing, including egg- and cell-based systems.

Pharmaceutical Technology
Viewpoint

October 02, 2010

In light of compendial changes, representatives of the US Pharmacopeia and an industry consortium provide perspectives on cap and ferrule labels.

The authors developed a formulation for effervescent gastroretentive drug delivery techniques using ibuprofen as a model drug. They optimized the formulations by applying full factorial design.

Pharmaceutical Technology

President Obama and HHS eye innovation and countermeasures to protect public health.

Pharmaceutical Technology

The EDQM inspection program helps to ensure the quality of APIs on the European market.

Issue PDF
Pharmaceutical Technology

October 01, 2010

Vaccine Manufacturing Reborn